(Q83201817)
Statements
Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation (English)
Yung-Jue Bang
Seock-Ah Im
Sae-Won Han
Tae-You Kim
Noe Kyeong Kim
Kyung-Hun Lee
Dae Seog Heo
Pil Gyu Hwang
Yoon Kyung Jeon
Jee Hyun Kim